Markovich MP, Shohat T, Riklis I, Avni R, Yujelevski-Rozenblit D, Bassal R, Cohen D, Rorman E. Seroepidemiology of Toxoplasma gondii infection in the Israeli population. Epidemiol Infect. 2014 Jan;142(1):149-55. PubMed PMID: 23587449.

Epidemiol Infect. 2014 Jan;142(1):149-55. doi: 10.1017/S0950268813000903. Epub 2013 Apr 15.

Seroepidemiology of Toxoplasma gondii infection in the Israeli population.

Markovich MP(1), Shohat T, Riklis I, Avni R, Yujelevski-Rozenblit D, Bassal R, Cohen D, Rorman E.

Author information:
(1)Israel Center for Diseases Control, Israel Ministry of Health, Tel-Hashomer, Israel.

Toxoplasmosis seroprevalence varies considerably between countries. We studied the seroprevalence of Toxoplasma gondii IgG antibodies in a national sample of the Israeli population; 2794 sera were tested. The highest age-adjusted seroprevalence rate was in Arabs (non-Bedouins) (60.4%), significantly higher compared to the rate in Jews (19.9%) and Bedouins (27.5%) (P < 0.01). There were no significant gender differences. Seropositivity increased with age in all population groups. For Jews, seropositivity was associated with place of birth and socioeconomic status. A finding of low seroprevalence rate in Bedouins despite their poor living conditions and close contact with livestock is surprising, and might be attributed to the dry and hot climate conditions in their area of residence. In women of reproductive age the seroprevalence was 15.1% in Jews, 25.4% in Bedouins and 72.3% in Arabs (non-Bedouins). Thus, the majority of pregnant women are susceptible to primary infection with T. gondii, and the risk for congenital toxoplasmosis remains high.

PMID: 23587449  [PubMed - indexed for MEDLINE]

האתר מעודכן נכון לתאריך:  17/04/2017 15:47:01
עבור לתוכן העמוד